Buscar en
European Journal of Psychiatry
Toda la web
Inicio European Journal of Psychiatry
Información de la revista
Vol. 37. Núm. 4.
(Octubre - Diciembre 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 37. Núm. 4.
(Octubre - Diciembre 2023)
Review article
Anxiety symptoms and disorders during the COVID-19 pandemic in children and adolescents: Systematic review and meta-analysis
Urvashi Panchala,b, Julio David Vaquerizo-Serranoa, Ileana Conde-Ghigliazzaa, Herdem Aslan Gençe,v, Simone Marchinif,g, Kamile Pociuteh, Binay Kayan Ocakoğlui, Szarah Sanchez-Romanj, Dorottya Orik,l, Ana Catalanc,m, Luis Alamedan,o,u, Samuele Cortesep,q,r,s,t, Gonzalo Salazar de Pabloa,c,d,w,
Autor para correspondencia
gonzalo.salazar_de_pablo@kcl.ac.uk

Corresponding author at: Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, PO63, 16 De Crespigny Park, SE5 8AF London, UK.
a Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK
b The Havens Sexual Assault Referral Centre, King's College Hospital NHS Foundation Trust, London, UK
c Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK
d Child and Adolescent Mental Health Service, South London and Maudsley National Health Service Foundation Trust, UK
e Department of Psychiatry, Koç University School of Medicine, Istanbul, Turkey
f Department of Psychiatry for Infant, Child, Adolescent and Youth, University Hospital Brussels (HUB), Brussels, Belgium
g Day care center for Adolescents, Equipe ASBL, Brussels, Belgium
h Vilnius University, Faculty of Medicine, Vilnius, Lithuania
i Clinic of Child and Adolescent Psychiatry, Bakirkoy Research and Training Hospital for Psychiatric and Neurological Diseases, University of Health Sciences, Istanbul, Turkey
j Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
k Department of Mental Health, Heim Pal National Pediatic Institute, Budapest, Hungary
l Institute of Behavioural Sciences, Semmelweis University, Budapest, Hungary
m Biobizkaia Health Research Institute, Basurto University Hospital, OSI Bilbao-Basurto, University of the Basque Country UPV/EHU, Centro de Investigación en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III. Plaza de Cruces 12. 48903, Barakaldo, Bizkaia, Spain
n Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College of London, London, UK
o Centro Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocio, Departamento de Psiquiatria, Universidad de Sevilla, Sevilla, Spain
p Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK
q Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK
r Solent NHS Trust, Southampton, UK
s Hassenfeld Children's Hospital at NYU Langone, New York University Child Study Center, New York City, NY, USA
t Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, Nottingham, UK
u Service of General Psychiatry, Treatment and Early Intervention in Psychosis Program, Lausanne, University Hospital (CHUV), Lausanne, Switzerland
v Research Center for Translational Medicine, Koç University, Istanbul, Turkey
w Institute of Psychiatry and Mental Health, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERSAM, Madrid, Spain
Ver más
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (6)
Mostrar másMostrar menos
Tablas (1)
Table 1. Test for heterogeneity.
Material adicional (1)
Abstract
Background and Objectives

The COVID-19 pandemic and its associated factors have been shown to affect anxiety levels of young people. We meta-analytically assessed the prevalence of anxiety symptoms and anxiety disorders in children and adolescents during the pandemic, and the predictors and moderating factors influencing anxiety.

Methods

Multiple databases and registers were searched in this PRISMA and MOOSE-compliant systematic review and meta-analysis (PROSPERO:CRD42021266695) until 27/06/2021. We included individual studies evaluating the prevalence and characteristics of anxiety symptoms or anxiety disorders in children and adolescents (mean age ≤18 years), during the COVID-19 pandemic. Data extraction and quality assessment were carried out by independent authors. Random-effects meta-analyses of the prevalence of anxiety symptoms and anxiety disorders were conducted using Comprehensive Meta-Analysis (CMA) V3.

Results

74 articles (total participant sample=478,882) were included (mean age=13.4 years, 52.3% female). The pooled rate of children and adolescents fulfilling diagnostic criteria for anxiety disorders was 13.0% (95%CI=4.9–30.1); the pooled prevalence of anxiety symptoms was 26.5% (95%CI=20.3–33.9). Anxiety symptoms were significantly more prevalent in females than males (B = 0.103, p<.001), significantly higher during the second wave of COVID-19, following July 2020, than during the first wave, prior to June 2020, (Q= 8.136, p=.017), and during school closure (Q= 8.100, p=.014). Quality of included studies was overall moderate.

Conclusions

There is a high prevalence of anxiety symptoms in children and adolescents during the COVID-19 pandemic, especially amongst females. This study identifies vulnerable groups, risk, and protective factors, which is crucial to developing clinical practice to prevent further mental health deterioration in young people.

Keywords:
Anxiety
Children
Adolescents
COVID-19

Artículo

Opciones para acceder a los textos completos de la publicación European Journal of Psychiatry
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 19,34 €

Comprar ahora
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos